Placental Aetiologies Of Foetal Growth Restriction: Clinical And Pathological Differences
Background: Placental morphology and pregnancy outcome differ between normal pregnancies and those with foetal growth restriction (FGR). Most reports do
Background: Placental morphology and pregnancy outcome differ between normal pregnancies and those with foetal growth restriction (FGR). Most reports do
Exogenous hyperisulinemia causes intrauterine growth restriction (IUGR) and abrogation of the normal gestational blood pressure (BP) decline in rats, associated
Objective: To identify pathological placental differences between early- and late-onset preeclampsia, in terms of fetal growth restriction (FGR). Study Design: The placentas
Objective: To determine the role of the placenta in controlling the circulatory levels of IL-1β and its natural inhibitor IL-1
Objective: The fetomaternal interface once thought to be an immune privilege site is now known to harbor a large population of
Background: Hypercoagulability plays an important role in recurrent abortion. We developed a plasminogen activator inhibitor (PAI-1) antagonist (Neuropharmacology 2010; 58:
Introduction: Gestational diabetes mellitus (GDM) is associated with adverse fetal outcome, and it is unclear why some are severely affected
Human cytomegalovirus (HCMV) is the leading cause of congenital infection, associated with severe birth defects and intrauterine growth retardation. The